Xyall and Indica Labs forge global collaboration
The partnership is designed to bridge the gap between histopathology and molecular pathology
The partnership is designed to bridge the gap between histopathology and molecular pathology
From cancer research to diagnostic solutions
Independent assessment of pharmaceutical, diagnostic and hospital facilities demonstrate that GENERATIONS, significantly impacts on waste-related Scope 3 emissions
The new partnership will aim to advance the development of antigen-targeted EVOC probes for early cancer detection
Labcon shares how elements found in some filter tip brands may explain unexpected assay failure
Join industry leaders across Europe in therapeutic drug development to share insights, drive investment, and build new partnerships
The device promises great performance, low price, and short lead time
Uniting executives from across the pharmaceutical industry to provide insights into accelerated drug discovery and clinical research through artificial-intelligence.
Strategic partnership aims to accelerate biomarker development to improve the diagnosis of Alzheimer’s disease and and other neurological disorders
The new electron diffractometers will enable analysis of structures impossible to measure with X-ray techniques
New agreement enhances high-parameter panels on Cytek cell analysis systems
The launch of Do Bio celebrates the growth of the company's expertise in microfluidics and biology
New partnership will unlock fully automated cell line production